Sensitizing substances including isobornyl acrylate ( IBOA ) in diabetes devices are predicted as skin sensitizers by the non‐animal assay KeratinoSens™ —Are better preventive approaches possible?
Contact Dermatitis · 2024
DOI: 10.1111/cod.14581 ↗Kurz gefasst
Fallbericht in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Madeleine Sjöberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Acrylates, Dermatitis, Allergic Contact, Camphanes. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Andrea Montano Montes, Carola Lidén, Hanna L Karlsson
Förderung
- Karolinska Institutet
Zitieren
APA
Sjöberg, M., Carlander, U., Montes, A. M., Lidén, C., & Karlsson, H. L. (2024). Sensitizing substances including isobornyl acrylate ( IBOA ) in diabetes devices are predicted as skin sensitizers by the non‐animal assay KeratinoSens™ —Are better preventive approaches possible?. Contact Dermatitis. https://doi.org/10.1111/cod.14581
Vancouver
Sjöberg M, Carlander U, Montes AM, Lidén C, Karlsson HL. Sensitizing substances including isobornyl acrylate ( IBOA ) in diabetes devices are predicted as skin sensitizers by the non‐animal assay KeratinoSens™ —Are better preventive approaches possible?. Contact Dermatitis. 2024. doi:10.1111/cod.14581
BibTeX
@article{Sjberg2024,
author = {Sjöberg, Madeleine and Carlander, Ulrika and Montes, Andrea Montano and Lidén, Carola and Karlsson, Hanna L},
title = {Sensitizing substances including isobornyl acrylate ( IBOA ) in diabetes devices are predicted as skin sensitizers by the non‐animal assay KeratinoSens™ —Are better preventive approaches possible?},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14581}
}
EUVIMED